GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Biosenta Inc (XCNQ:ZRO) » Definitions » Tax Expense

Biosenta (XCNQ:ZRO) Tax Expense : C$0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Biosenta Tax Expense?

Biosenta's tax expense for the months ended in Dec. 2024 was C$0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was C$0.00 Mil.


Biosenta Tax Expense Historical Data

The historical data trend for Biosenta's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosenta Tax Expense Chart

Biosenta Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biosenta Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Biosenta Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biosenta  (XCNQ:ZRO) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Biosenta Tax Expense Related Terms

Thank you for viewing the detailed overview of Biosenta's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosenta Business Description

Traded in Other Exchanges
N/A
Address
18 Wynford Drive, Suite 704, Toronto, ON, CAN, M3C 3S2
Biosenta Inc is a Canada based company focused on producing and deploying anti-microbial products and remediation solutions to the marketplace for retail, institutional and industrial users. It is engaged in developing sales for its True product lines and the development for commercial applications of its technology to produce an antimicrobial Tri-Filler product. The company's anti-microbial products kill mold, bacteria, and fungi on contact and prevent re-growth. ZeroMold helps contractors to build mold-resistant buildings and provide consumers with a solution to their mold problem. The firm also manufactures and distributes a proprietary anti-microbial filler product for the industrial sector.
Executives
Amarvir Gill Director, Senior Officer
Dene Rogers Senior Officer

Biosenta Headlines

No Headlines